scholarly journals Central venous catheter based closed thoracic drainage in the treatment of tuberculous pleuritis

2019 ◽  
Vol 35 (4) ◽  
Author(s):  
Ling Song ◽  
Yueling Zhang ◽  
Qiong Jia
Keyword(s):  
Quality Of Life ◽  
Treatment Group ◽  
Central Venous Catheter ◽  
Venous Catheter ◽  
Control Group ◽  
Central Venous ◽  
Thoracic Drainage ◽  
Significant Difference ◽  
Tuberculous Pleurisy

Objective: To explore the clinical effect of central venous catheter closed thoracic drainage in the treatment of tuberculous pleurisy. Methods: One hundred and four patients with tuberculous pleurisy who were admitted to Binzhou People’s Hospital from August 2016 to August 2017 were divided into a control group and a treatment group according to random number table method, 52 each. The control group was treated with conventional pleural puncture and drainage, while the treatment group was treated with closed central venous catheter based thoracic drainage. The clinical efficacy, improvement time of clinical symptoms, total volume of drainage, pleural thickness, and improvement of quality of life and occurrence of adverse reactions were compared between the two groups. Results: Pleural effusion, fever and chest tightness of the treatment group disappeared earlier (P<0.05); the hospitalization time in the treatment group was less than that in the control group (P<0.05); the total amount of drainage in the treatment group was lower than that in the control group (P<0.05); the pleural thickness of the treatment group was higher than that in the control group (P<0.05); the quality of life score in the treatment group was significantly higher than that in the control group (P<0.05). The total effective rates of the treatment group and the control group were 93.5% and 85%, respectively, with a significant difference (P<0.05). The incidence of adverse reactions in the treatment group was significantly lower than that in the control group, with a significant difference (P<0.05). Conclusion: Central venous catheter based closed thoracic drainage is more effective than conventional thoracic puncture and drainage in the treatment of tuberculous pleurisy. It can accelerate the improvement of clinical symptoms, improve the quality of life of patients, and reduce the incidence of complications. It is worth popularizing and applying. doi: https://doi.org/10.12669/pjms.35.4.63 How to cite this:Song L, Zhang Y, Jia Q. Central venous catheter based closed thoracic drainage in the treatment of tuberculous pleuritis. Pak J Med Sci. 2019;35(4):---------. doi: https://doi.org/10.12669/pjms.35.4.63 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

scholarly journals Clinical Analysis of the Treatment of Exudative Tuberculous Pleurisy with Central Venous Catheter Drainage

2015 ◽  
Vol 4 (4) ◽  
pp. 1
Author(s):  
Aijun Jia
Keyword(s):  
Treatment Group ◽  
Central Venous Catheter ◽  
Clinical Effect ◽  
Venous Catheter ◽  
Clinical Analysis ◽  
Control Group ◽  
Central Venous ◽  
Catheter Drainage ◽  
Tuberculous Pleurisy ◽  
Positive Effect

<p><strong>Objective:</strong> To evaluate the clinical effect of the treatment of exudative tuberculous pleurisy with central venous catheter drainage. <strong>Methods:</strong> 60 cases of exudative tuberculous pleurisy were divided into two groups. The treatment group was treatedwith central venous catheter drainage, while the control group was treated with multipleconventional thoracentesis. <strong>Results:</strong> The clinical effect of the treatment group was significantlyhigher in comparison to the control group (<em>p</em> &lt; 0.01). The adverse reaction of the treatment group was significantly lower in contrast to the control group (<em>p</em> &lt; 0.01). <strong>Conclusion:</strong> Application of central venous catheter drainage in the treatment of exudativetuberculous pleurisy revealed a positive effect, by showing less adverse reaction.Therefore, the treatment is worth to be promoted for clinical application.</p>

scholarly journals PENGARUH PEMBERIAN INHALASI KOMBINASI SALMETEROL/FLUTIKASON PROPIONAT TERHADAP KUALITAS HIDUP PENDERITA PENYAKIT PARU OBSTRUKTIF KNONIK STABIL

2019 ◽  
Vol 1 (2) ◽  
pp. 28-33
Author(s):  
Refi Sulistiasari
Keyword(s):  
Quality Of Life ◽  
Clinical Trial ◽  
Treatment Group ◽  
Control Group ◽  
Copd Assessment Test ◽  
Copd Patients ◽  
Significant Difference ◽  
Inhaled Therapy ◽  
St George's Respiratory Questionnaire

It is known that inflammation is the underlying cause of COPD, and this affects to quality of life of the patient. Provision of inhaled therapy combination of LABA and corticosteroids is one of therapy in pharmacology of stable PPOK patients. The aim of this study was to know the benefits of inhalation of 50 g / fluticasone propionate 500 g inhibition in stable COPD patients. The research design is clinical trial. The study was conducted for 3 months and was performed on 26 stable COPD patients divided into two groups: 15 patients for the treatment group and 15 patients for the control group. After the measurements were obtained, there was a significant difference in the quality of life as measured by St. George's Respiratory Questionnaire (SGRQ) (p = 0.001) and COPD Assessment Test (CAT) (0.001) measurements were made twice on the first and thirtieth days.

Effect of chlorhexidine gluconate and benzydamine hydrochloride mouth spray on clinical signs and quality of life of patients with streptococcal tonsillopharyngitis: multicentre, prospective, randomised, double-blinded, placebo-controlled study

2011 ◽  
Vol 125 (6) ◽  
pp. 620-625 ◽  
Author(s):  
C Cingi ◽  
M Songu ◽  
A Ural ◽  
N Erdogmus ◽  
M Yildirim ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Treatment Group ◽  
Antibiotic Treatment ◽  
Clinical Signs ◽  
Chlorhexidine Gluconate ◽  
Controlled Study ◽  
Control Group ◽  
Control Groups ◽  
Significant Difference

AbstractObjective:To assess the effect of chlorhexidine gluconate and benzydamine hydrochloride mouth spray, used in conjunction with antibiotic treatment, on the intensity of clinical signs and quality of life of patients with group A streptococcal tonsillopharyngitis.Methods:Patients (n = 147) with streptococcal tonsillopharyngitis were recruited and randomly allocated to either the treatment group (penicillin plus chlorhexidine and benzydamine; n = 72) or control group (penicillin plus placebo; n = 75). Blinded assessments were conducted before and after 10 days' treatment, using an intensity rating scale for clinical sign severity, a visual analogue scale for subjective health state, the Short Form 36 Health Questionnaire for quality of life, and a customised questionnaire for side effects.Results:The treatment group showed a statistically significant reduction in the intensity of clinical signs, compared with the control group. On treatment day 7, there was no significant difference in quality of life between the treatment and control groups. The treatment drugs were well tolerated, and no serious adverse events were observed.Conclusion:Chlorhexidine gluconate and benzydamine hydrochloride mouth spray, added to standard antibiotic treatment, significantly alleviate the intensity of clinical signs in patients with streptococcal pharyngitis. Further research is needed using larger sample sizes or alternative control groups.

scholarly journals PENGARUH PEMBERIAN INHALASI KOMBINASI SALMETEROL/FLUTIKASON PROPIONAT TERHADAP KUALITAS HIDUP PENDERITA PENYAKIT PARU OBSTRUKTIF KNONIK STABIL

2019 ◽  
Vol 1 (2) ◽  
pp. 28-33
Author(s):  
Refi Sulistiasari
Keyword(s):  
Quality Of Life ◽  
Clinical Trial ◽  
Treatment Group ◽  
Control Group ◽  
Copd Assessment Test ◽  
Copd Patients ◽  
Significant Difference ◽  
Inhaled Therapy ◽  
St George's Respiratory Questionnaire

It is known that inflammation is the underlying cause of COPD, and this affects to quality of life of the patient. Provision of inhaled therapy combination of LABA and corticosteroids is one of therapy in pharmacology of stable PPOK patients. The aim of this study was to know the benefits of inhalation of 50 mg / fluticasone propionate 500 mg inhibition in stable COPD patients. The research design is clinical trial. The study was conducted for 3 months and was performed on 26 stable COPD patients divided into two groups: 15 patients for the treatment group and 15 patients for the control group. After the measurements were obtained, there was a significant difference in the quality of life as measured by St. George's Respiratory Questionnaire (SGRQ) (p = 0.001) and COPD Assessment Test (CAT) (0.001) measurements were made twice on the first and thirtieth days.

scholarly journals Pregnancy Outcome in Late-onset Severe OHSS Patients Following Different Ascetic Fluid Drainage and Comparison With the Non-OHSS IVF Patients

2020 ◽  
Author(s):  
Ren YUN ◽  
rong li ◽  
Yang Shuo ◽  
Yang Rui ◽  
Song Dong hong ◽  
...  
Keyword(s):  
Central Venous Catheter ◽  
Pregnancy Outcome ◽  
Live Birth ◽  
Late Onset ◽  
Multiple Pregnancy ◽  
Venous Catheter ◽  
Control Group ◽  
Central Venous ◽  
Significant Difference ◽  
Severe Ohss

Abstract Introduction： Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic serious complication during assisted reproductive technology, the aim of our research is to explore the differences of pregnancy outcome between severe OHSS patients and the non-OHSS IVF patients, and also compare the pregnancy outcome of different ascites drainage way of severe OHSS patients.Design: This is a retrospective cohort analysis carried out in a University-affiliated reproductive center from 2012 to 2019 ,between 359 women with severe OHSS following ascites draining and 345 non-OHSS women (matched by age and retrieved oocyte number).We examined the rates of clinical pregnancy, multiple pregnancies, miscarriage, live birth and preterm delivery between the two groups. Within the OHSS group (central venous catheter group vs paracentesis group), odds ratios (ORs) and 95% confidence intervals (CIs) of measure of clinical pregnancy were also analyzed.Result： The biochemical pregnancy loss rate of non-OHSS patients was significantly higher than that of severe OHSS patients (11.1% vs 0.6%) , the live birth, multiple pregnancy (twin pregnancy ) was much more in severe OHSS group than in control group(88.9% vs 73.5%; 57.6% vs 28.1% respectively), and there was no significant difference between singleton and twin preterm rate and neonatal birth weight between OHSS and control group. Binary logistic regression analysis revealed multiple pregnancy and long-protocol showed relatively high odds ratio, suggest that thelong-protocol of COS and multiple pregnancy are the risk factor of severe OHSS.Among severe OHSS following ascites draining, in comparison with abdominal paracentesis and central venous catheter, the ascites volume in central venous catheter group was much more than abdominal paracentesis group, there was significant difference between the two groups. There was no significant difference between the two groups in comparison of live birth, and the birth weight of singleton and twin between these two groups. but the premature birth rate of singleton in group 1 was 9.3% (10/107), whereas in group 2, it was 3.75%.Conclusion： In conclusion, this preliminary report suggests that for the IVF-ET patients, less basic follicle number, GnRH antagonist cycle, singleton maybe the protective factors for the late-onset OHSS. Paracentesis and central venous catheter are all the effective modality to manage the ascites for the severe OHSS patients. For the patients who have the possibility of repeated paracentesis, catheter is a safe and effective way.

Advantages of Totally Implanted Port over Impromptu Short-Term Central Venous Catheter in Oncological Pain Therapy

2003 ◽  
Vol 4 (2) ◽  
pp. 50-55 ◽  
Author(s):  
C. Reale ◽  
E. Vernaglione ◽  
C.A. Reale ◽  
A. Mancini ◽  
M. Prologo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Central Venous Catheter ◽  
Pain Therapy ◽  
Venous Catheter ◽  
Brief Pain Inventory ◽  
Venous Access ◽  
Central Venous ◽  
Short Term ◽  
Randomised Study

The aim of this paper is to determine if patient controlled analgesia (PCA) by means of programmable pumps improves patients' autonomy and to verify if the short-term central venous catheter - implanted when pain is first evident - makes the quality of life worse in comparison with an early implanted port. Forty non-terminally ill patients affected by urinary malignant pathologies with visceral and bone metastases were enrolled in a prospective and randomised study at the Urology Department of “La Sapienza” University in Rome, Italy. Intensity of pain and tolerability of venous access were assessed for the first 7 days, and weekly for 3 months. Such data were used to adjust drug therapy. In this study we hypothesized that a delayed central venous catheter implant, when the pain is at first considerably evident, can interfere negatively with drug treatment. The visual analogue scale (VAS) and the brief pain inventory (BPI) were administered to the patients, and these showed good levels of analgesia in both groups and a greater comfort to the patients with the previously implanted port in comparison with a short-term central venous catheter. In conclusion, PCA achieves a constant level of drugs and enables the patient to voluntary control the pain by means of supplemental boluses. Both central devices seem to provide similar technical benefits, but the port is much more easily tolerated and the quality of life is increased if it is already available when pain is first evident.

Home Intermittent Amrinone Infusions in Terminal Congestive Heart Failure

DICP ◽  
1989 ◽  
Vol 23 (1) ◽  
pp. 59-62 ◽  
Author(s):  
Richard J. Baptista ◽  
Francis P. Mitrano ◽  
Joanne Perri-Lafrancesca
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Congestive Heart Failure ◽  
Central Venous Catheter ◽  
Infusion Pump ◽  
Venous Catheter ◽  
Pilot Program ◽  
Central Venous ◽  
At Home

The prevalence of congestive heart failure (CHF) and its progressive degenerative course continue to generate pressure for alternative, more effective means of treatment. A confluence of factors, including the number of Americans with CHF, the spiraling costs of hospital care, and increasing interest in cost-effective home care, contribute to the current efforts to develop an effective, nontoxic therapy that effectively increases myocardial contractility and output and can be administered within the confines of the home. Given that preliminary clinical trials in the hospital setting with amrinone have produced positive results, the transition of this therapy to the home, when administered intermittently via central venous catheter and infusion pump, was undertaken. In order to prolong and increase quality of life in terminal CHF patients, intermittent amrinone infusions were provided at home to four patients as part of our pilot program. All four patients met the criteria for New York Heart Association (NYHA) functional class IV heart failure, and none had responded to conventional therapy suitable for outpatient maintenance. The patients also shared strong family support and an intense desire to improve the quality of remaining life. All four patients and designated family members were trained in the specifics of aseptic technique, medication dose preparation, central venous catheter care, and operation of an infusion pump. An ambulatory pump was used in three of the four patients. Subsequent to the initiation of intermittent home amrinone infusions, all four patients had greater tolerance to limited exercise and/or ambulation secondary to increased cardiac output and diuresis. Patients survived 8, 10, 47, and 56 weeks. This pilot program suggests that intravenous amrinone, administered intermittently at home, appears reasonably safe and might promote an improved quality of life. More research is necessary prior to substantiating any firm conclusions.

scholarly journals Parental Narratives of Quality of Life in Children with Leukemia as Associated with the Placement of a Central Venous Catheter

2005 ◽  
Vol 30 (6) ◽  
pp. 544-552 ◽  
Author(s):  
Marta Tremolada ◽  
Vanna Axia ◽  
Marta Pillon ◽  
Sara Scrimin ◽  
Fabia Capello ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Central Venous Catheter ◽  
Venous Catheter ◽  
Central Venous

scholarly journals GLUCOCORTICOSTEROID DURING PATCH APPLICATION TO IMPROVE SCAR OUTCOME AFTER CENTRAL VENOUS CATHETER. A RANDOMIZED TRIAL

2021 ◽  
Author(s):  
Ida Bo Nissen ◽  
Mette Møller Handrup ◽  
Karen Bang ◽  
Henrik Hasle
Keyword(s):  
Placebo Group ◽  
Central Venous Catheter ◽  
Fusidic Acid ◽  
Intervention Group ◽  
Venous Catheter ◽  
Control Group ◽  
Neoplastic Disease ◽  
Central Venous ◽  
Silicone Gel ◽  
Significant Difference

Introduction: Children treated for cancer with a central venous catheter are often bothered by scarring. We studied whether glucocorticosteroid during patch occlusion has a beneficial effect on scar outcome in children and adolescents treated for neoplastic disease. Methods: A double-blinded placebo-controlled randomized clinical trial was performed. The main outcome was the Vancouver Scar Scale (VSS). Secondary outcomes were scar width and scar quality measured using the Patient and observer scar assessment (POSAS). The patients were divided into an intervention groups and a control group. The intervention group was randomized into two groups; Active and placebo group. The active treatment consisted of cream with glucocorticosteroid and fusidic acid. The placebo treatment consisted of cream with fusidic acid. Both groups were also treated with a silicone gel patch for three months after central venous catheter removal. The control group did not receive any specific skin care. Results: Assessment at 6 months were completed for 44 in the intervention group (21 in the active and 23 in the placebo group) and 47 in the comtrol group. The intervention group had a significantly lower VSS and a smaller scar compared to the control group (p = 0.00, p = 0.02). The POSAS by the patients and the study nurse showed no significant difference between the intervention and control groups (p = 0.84, p= 0.36). Conclusions: Silicone gel sheet alone or in combination with application of glucocorticosteroid during sheet occlusion improved scar outcome after removal of central venous catheter in children treated for neoplastic diseases.

Empowering the Role of the Integrated Foster Post Cadres in Improving the Quality of Life of Diabetes Mellitus Patients

2021 ◽  
Vol 2 (3) ◽  
pp. 128-138
Author(s):  
Fitri Firranda Nurmalisyah ◽  
Alik Septian Mubarok ◽  
Desy Siswi Anjar Sari
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Treatment Group ◽  
Social Relations ◽  
Health Workers ◽  
Signs And Symptoms ◽  
Control Group ◽  
Quality Life ◽  
Significant Difference

Introduction: Nurses as one of the health workers have a role in managing Diabetes Mellitus patients, the quality life of Diabetes Mellitus patients affects physical health, psychological conditions, level of dependence, social relations and the patient's relationship with the surrounding environment. Actions and interventions in controlling Diabetes Mellitus disease require appropriate therapeutic regimens, as well as involving families. By empowering the health cadres, it can improve the quality life of people with Diabetes Mellitus who are in the working area of the Kesamben Health Center, Jombang Regency. Methods: This research is a quasi-experimental study with a non-randomized control group pre-test post- test design. In this study, the treatment group was given a treatment in the form of training for Integrated Foster Post Cadres to improve for Diabetes Mellitus, while the control group was not given any treatment. Results: The results showed that there was a significant difference in the quality of life between the treatment group and the control group due to skills improvement training for Integrated Foster Post Cadres Diabetes Mellitus with the results of the independent t test on self-efficacy obtained t value of 25.055 (p = 0.000), while the value t of quality life is 25,790 (p = 0,000). Conclusion: Nurses can empower Integrated Foster Post Cadres in the community by improving the quality of life for people with Diabetes Mellitus. Integrated Foster Post Cadres play an active role in the community in the scope of knowledge, signs and symptoms, complications of Diabetes Mellitus which can encourage DM sufferers to be motivated to improve the quality of life.

Sign in / Sign up

Export Citation Format

Share Document